出典:Wikipedia
出典:『Wikipedia』 (2011/06/19 18:56 UTC 版)
Gliclazide is an oral hypoglycemic (anti-diabetic drug) and is classified as a sulfonylurea. It is marketed as Glyloc and Reclide in India and Diamicron in Canada. In the Philippines, it is marketed as Glubitor-OD. It is not marketed in the United States. A modified-release formulation is also marketed. Its classification has been ambiguous, as literature uses it as both a first-generation and second-generation sulfonylurea.